[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"submucosal-esophageal-adenocarcinoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:submucosal-esophageal-adenocarcinoma":48},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100302859",false,"NCT03222635","Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma","Endoscopic Management of Patients With High Risk T1a and T1b N0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.","PREFER","Inclusion Criteria:\n\n* Patients with submucosal or high-risk mucosal EAC diagnosed in an ER specimen, by an expert gastrointestinal (GI) pathologists.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Prior history of high-risk mucosal or ≥T1sm.\n* Synchronous esophageal squamous cell carcinoma.\n* Suspicion on lymph node metastasis or distant metastasis on EUS, ultrasound of the neck or CT-thorax-abdomen performed six weeks after ER during baseline measurement.\n* Tumor-positive deep resection margin (R1) in ER specimen.\n* Patients unable to give signed informed consent.","ALL","18 Years",{"count":19,"type":20},225,"ESTIMATED","INTERVENTIONAL",[23],"NA","Aim of this prospective multicenter study is to evaluate the safety of an endoscopic follow-up strategy in patients treated with endoscopic resection (ER) for submucosal or high-risk mucosal esophageal adenocarcinoma (T1bN0M0 or HR T1aN0M0 EAC).",[26,27,28],"Submucosal Esophageal Adenocarcinoma","Barrett Esophagus","High-risk Mucosal Esophageal Adenocarcinoma",[30,31,32,33,34],"Barrett's esophagus","Submucosal esophageal adenocarcinoma","Endoscopic treatment","Endoscopic follow-up","High-risk mucosal esophageal adenocarcinoma","RECRUITING","2024-07-23",{"date":38,"type":39},"2024-07-24","ACTUAL",{"date":41,"type":39},"2017-07-25",{"date":43,"type":20},"2028-07-25",{"name":45,"class":46},"Amsterdam UMC","OTHER",20,""]